We also lost subjects by including variables known to be related to aging/mortality, such as the albumin creatinine ratio, heart rate and disease/treatment variables such as treated dyslipidemia, for which completeness ranges between 86% and 90%. This evidence concerns the gene ALB and metabolic syndrome.